期刊文献+
共找到50篇文章
< 1 2 3 >
每页显示 20 50 100
Screening of Epstein-Barr Virus Early Antigen Expression Inducers from Chinese Medicinal Herbs and Plants 被引量:3
1
作者 ZENG YI ZHONG JI +4 位作者 AN-MING YE SHU-QING NI ZHI-Yu MIAO XUL-QIAN MO YONU-KUN AND LI ZE-LIN(Institute of Virology, Chinese Academy ’ of ’Preventive Medicine, Beijing,)(Nasopharyngeal Control and Treatmenl Institute of Cangwu, Guangxi,Guangxi Herbs Bitany 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 1994年第1期50-55,共6页
Ether extrilcls of 1693 Chinesc medicinal herbs and plilnts from 268 families werestudied for the induction of Epstcin-Barr viral (EBV ) early antigcn (EA ) expression in theRaji cell line. Fifty-two from 18 families ... Ether extrilcls of 1693 Chinesc medicinal herbs and plilnts from 268 families werestudied for the induction of Epstcin-Barr viral (EBV ) early antigcn (EA ) expression in theRaji cell line. Fifty-two from 18 families were found to have inducing activity. Twenty-fiveand seven of them were from Euphorbiaccae and Thymclaeaceae, respectively. Some ofthem, such as Croton tiglium, Euphorbia kansui, Daphnc genkwa, Wikstrocmia chamacdaphen, Wikstroemia indica, Prunus mandshurica Koehne and Achyranthes bidentata arecommonly used drugs. The significance of these herbs in the activation of EBV in vivo andtheir relation to the development of nasopharyngeal carcinoma were discussed. 展开更多
关键词 In Screening of epstein-barr virus Early antigen Expression Inducers from Chinese Medicinal Herbs and Plants Raji
下载PDF
Nuclear factor κB represses the expression of latent membrane protein 1 in Epstein-Barr virus transformed cells 被引量:2
2
作者 Mingxia Cao Qianli Wang +1 位作者 Amy Lingel Luwen Zhang 《World Journal of Virology》 2014年第4期22-29,共8页
AIM: To investigate the role of nuclear factor κB(NF-κB) in the regulation of Epstein-Barr virus(EBV) latent membrane protein 1(LMP1) in EBV transformed cells. METHODS: LMP1 expression was examined in EBV transforme... AIM: To investigate the role of nuclear factor κB(NF-κB) in the regulation of Epstein-Barr virus(EBV) latent membrane protein 1(LMP1) in EBV transformed cells. METHODS: LMP1 expression was examined in EBV transformed human B lymphocytes with modulation of NF-κB activity. RESULTS: EBV infection is associated with several human cancers. EBV LMP1 is required for efficient transformation of adult primary B cells in vitro, and is expressed in several pathogenic stages of EBVassociated cancers. Regulation of EBV LMP1 involves both viral and cellular factors. LMP1 activates NF-κB signaling pathway that is a part of the EBV transformation program. However, the relation between NF-κB and LMP1 expression is not well established yet. In this report, we found that blocking the NF-κB activity by Inhibitor of κB stimulated LMP1 expression, while the overexpression of NF-κB repressed LMP1 expression in EBV-transformed IB4 cells. In addition, LMP1 repressed its own promoter activities in reporter assays, and the repression was associated with the activation of NF-κB. Moreover, NF-κB alone is sufficient to repress LMP1 promoter activities. CONCLUSION: Our data suggest LMP1 may repress its own expression through NF-κB in EBV transformed cells and shed a light on LMP1 regulation during EBV transformation. 展开更多
关键词 nuclear factorκB epstein-barr virus LATENT membrane protein 1 LATENCY Transformation
下载PDF
STRUCTURE AND EXPRESSION OF EPSTEIN-BARR VIRUS MEMBRANE ANTIGEN IN RECOMBINANT VACCINIA VIRUS
3
作者 谷淑燕 江民康 +4 位作者 赵文平 曾毅 侯云德 朱既明 Hans Wolf 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1989年第1期44-49,共6页
The Epstein-Barr virus membrane antigen was constructed and inserted into vaccinia virus, Tian-tan strain in order to study the effect of this virus on EB infection and tumorogenesis. The EBV-derived membrane antigen ... The Epstein-Barr virus membrane antigen was constructed and inserted into vaccinia virus, Tian-tan strain in order to study the effect of this virus on EB infection and tumorogenesis. The EBV-derived membrane antigen was expressed under the control of a 7.5 K promoter of vaccinia virus. The antibody against the membrane antigen of EB virus was produced on rabbits vaccinated with recombinant vaccinia virus. 展开更多
关键词 EBV MA STRUCTURE AND EXPRESSION OF epstein-barr virus MEMBRANE antigen IN RECOMBINANT VACCINIA virus GENE
下载PDF
Structural and nucleic acid binding properties of hepatitis delta virus small antigen 被引量:1
4
作者 Carolina Alves Hong Cheng +4 位作者 Joao Paulo Tavanez Ana Casaca Severin Gudima Heinrich Roder Celso Cunha 《World Journal of Virology》 2017年第2期26-35,共10页
AIM To further characterize the structure and nucleic acid binding properties of the 195 amino acid small delta antigen, S-HDAg, a study was made of a truncated form of S-HDAg, comprising amino acids 61-195(?60HDAg), ... AIM To further characterize the structure and nucleic acid binding properties of the 195 amino acid small delta antigen, S-HDAg, a study was made of a truncated form of S-HDAg, comprising amino acids 61-195(?60HDAg), thus lacking the domain considered necessary for dimerization and higher order multimerization.METHODS Circular dichroism, and nuclear magnetic resonance experiments were used to assess the structure of ?60HDAg. Nucleic acid binding properties were investigated by gel retardation assays. RESULTS Results showed that the truncated ?60HDAg protein is intrinsically disordered but compact, whereas the RNA binding domain, comprising residues 94-146, adopts a dynamic helical conformation. We also found that ?60HDAg fails to multimerize but still contains nucleic acid binding activity, indicating that multimerization is not essential for nucleic acid binding. Moreover, in agreement with what has been previously reported for full-length protein, no apparent specificity was found for the truncated protein regarding nucleic acid binding.CONCLUSION Taken together these results allowed concluding that ?60HDAg is intrinsically disordered but compact; ?60HDAg is not a multimer but is still capable of nucleic acid binding albeit without apparent specificity. 展开更多
关键词 Hepatitis delta virus Delta antigen nuclear magnetic resonance Circular dichroism Intrinsically disordered protein
下载PDF
Liver angiogenesis as a risk factor for hepatocellularcarcinoma development in hepatitis C virus cirrhotic patients 被引量:3
5
作者 Roberto Mazzanti Luca Messerini +3 位作者 Camilla E Comin Lorenzo Fedeli Nathalie Gannè-Carrie Michel Beaugrand 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第37期5009-5014,共6页
AIM: To evaluate the predictive value of hepatocyte proliferation and hepatic angiogenesis for the occurrence of Hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) cirrhotic patients. METHODS: One hundred-five ... AIM: To evaluate the predictive value of hepatocyte proliferation and hepatic angiogenesis for the occurrence of Hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) cirrhotic patients. METHODS: One hundred-five patients (69 males, 36 females; age range, 51-90 year; median 66 year) with biopsy proven HCV cirrhosis were prospectively monitored for HCC occurrence for a median time of 64 mo. Angiogenesis was assessed by using microvessel density (MVD), hepatocyte turnover by MIB1 and PCNA indexes at inclusion in liver biopsies. RESULTS: Forty six patients (43.8%) developed HCC after a median time of 55 (6-120) mo while 59 (56.2%) did not. Patients were divided into two groups according to the median value of each index. The difference between patients with low (median MVD = 3; range 0-20) and high (median MVD = 7; range 1-24) MVD was statistically significant (χ2 = 22.06; P < 0.0001) which was not the case for MIB1 or PCNA (MIB-1: χ2 = 1.41; P = 0.2351; PCNA: χ2 = 1.27; P = 0.2589). The median MVD was higher in patients who developed HCC than in those who did not. HCC-free interval was significantly longer in patients with the MVD ≤ 4 (P = 0.0006). No relationship was found between MIB1 or PCNA and MVD (MIB-1 r2 = 0.00007116, P = 0.9281; PCNA: r2 =0.001950; P = 0.6692). MVD only was able to predict the occurrence of HCC in these patients. Among other known risk factors for HCC, only male sex was statistically associated with an increased risk. CONCLUSION: Liver angiogenesis has a role for in HCV- related liver carcinogenesis and for defining patients at higher risk. 展开更多
关键词 肝癌 肝炎病毒 增殖细胞 癌细胞
下载PDF
EBNA2免疫组化在EB病毒阳性淋巴组织疾病中的表达意义
6
作者 张燕林 贺文 +3 位作者 谢建兰 郑晓丹 郑媛媛 周小鸽 《诊断病理学杂志》 2024年第4期300-303,共4页
目的观察EBNA2免疫组化在不同EB病毒阳性淋巴组织疾病中的表达差异、分析其在病理诊断与鉴别诊断中的价值。方法收集344例EB病毒阳性的淋巴组织疾病,总结EBNA2免疫组化在病变中的表达特点。结果不同的EBV阳性淋巴组织病变,EBNA2的阳性... 目的观察EBNA2免疫组化在不同EB病毒阳性淋巴组织疾病中的表达差异、分析其在病理诊断与鉴别诊断中的价值。方法收集344例EB病毒阳性的淋巴组织疾病,总结EBNA2免疫组化在病变中的表达特点。结果不同的EBV阳性淋巴组织病变,EBNA2的阳性表达不同:IM中阳性39例(39/46),EBV阳性的弥漫大B细胞淋巴瘤3例(3/30),淋巴瘤样肉芽肿1例(1/5),纤维素相关弥漫大B细胞淋巴瘤2例(2/2),浆母细胞淋巴瘤1例(1/14),免疫相关淋巴组织增殖性疾病32例(32/58)(包括移植后淋巴组织增殖性疾病21例,HIV相关Burkitt淋巴瘤1例,HIV相关弥漫大B细胞淋巴瘤2例,原发免疫缺陷疾病相关淋巴组织疾病6例,医源性免疫相关淋巴组织增殖性疾病2例)。其余均显示EBNA2阴性。②不同病变中的EBNA2阳性细胞表达明显不同:传染性单核细胞增多症中的EBNA2阳性细胞相对较少,并且多呈散在分布,几乎很少见到簇状聚集的情况。EBNA2阳性细胞多表现为≤10个/HPF,少见11~50个/HPF,仅有个别病例显示大于50个/HPF。免疫相关淋巴组织增殖性疾病中,出现大量EBNA2阳性细胞,阳性细胞较弥漫分布,大部分为强阳性,并且阳性细胞多显示大于50个/HPF。结论EBNA2阳性在疾病的诊断及鉴别诊断提供了新的依据,具有一定的价值;当病变表达EBNA2时,提示患者可能存在免疫缺陷或处于免疫失调状态,对临床诊断及治疗具有一定的指导意义。 展开更多
关键词 EB病毒 淋巴组织疾病 传染性单核细胞增多症 EBV核抗原2
下载PDF
Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: a meta-analysis 被引量:8
7
作者 LI Shan DENG Yan +3 位作者 LI Xi CHEN Qiao-pei LIAO Xiang-cheng QIN Xue 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第9期1201-1205,共5页
Background Non-invasive nasopharyngeal carcinoma (NPC) screening usually involves serological testing for the presence of IgA antibodies to Epstein-Barr virus (EBV) capsid antigen (VCA). The present meta-analysi... Background Non-invasive nasopharyngeal carcinoma (NPC) screening usually involves serological testing for the presence of IgA antibodies to Epstein-Barr virus (EBV) capsid antigen (VCA). The present meta-analysis determined the accuracy of VCA-lgA in the diagnosis of NPC.Methods A systematic review of studies was conducted and data on the accuracy of VCA-lgA concentrations in the diagnosis of NPC were pooled using random effects models. Receiver operating characteristic curves were used to summarize the overall test performance. Results Twenty studies met the inclusion criteria for the meta-analysis. The summary estimates for VCA-lgA in the diagnosis of NPC were: sensitivity 0.91 (95% confidence interval (Cl): 0.90-0.92), specificity 0.92 (95% Cl: 0.92-0.93), positive likelihood ratio 31.65 (95% Cl: 10.99-91.15), negative likelihood ratio 0.10 (95% Cl: 0.07-0.13) and diagnostic odds ratio 414.59 (95% Cl: 174.96-982.42). The area under the summary receiver operating characteristic curves was 0.98.Conclusion The sensitivity and the specificity of serum VCA-lgA are very high, suggesting that the presence of VCA-lgA in peripheral blood is a valuable predictor for NPC. 展开更多
关键词 epstein-barr virus nasopharyngeal carcinoma virus capsid antigen diagnosis META-ANALYSIS
原文传递
5-Aza-CdR联合EBNA1-DC疫苗诱导的淋巴细胞对鼻咽癌C666-1细胞的杀伤作用
8
作者 谢云青 黄丽洁 +2 位作者 林晓为 陈莉 陈珊珊 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2023年第8期701-706,共6页
目的:探讨EB病毒核抗原1(EBNA1)mRNA修饰的DC(EBNA1-DC)诱导的淋巴细胞联合甲基化抑制剂5-Aza-CdR对鼻咽癌C666-1细胞的杀伤作用。方法:以构建的EBNA1-pCDNA3.1质粒为模板,体外转录获得EBNA1 mRNA,通过脂质体转染至健康人外周血来源DC,... 目的:探讨EB病毒核抗原1(EBNA1)mRNA修饰的DC(EBNA1-DC)诱导的淋巴细胞联合甲基化抑制剂5-Aza-CdR对鼻咽癌C666-1细胞的杀伤作用。方法:以构建的EBNA1-pCDNA3.1质粒为模板,体外转录获得EBNA1 mRNA,通过脂质体转染至健康人外周血来源DC,构建EBNA1-DC疫苗。流式细胞术检测转染后DC表型及5-Aza-CdR处理后的C666-1细胞凋亡情况。实时无标记动态细胞分析技术检测EBNA1-DC疫苗诱导的淋巴细胞联合5-Aza-CdR的特异性抗肿瘤活性。结果:转染EBNA1 mRNA后EBNA1-DC表面EBNA1阳性率为(59.3±5.85)%,HLA-DR的表达与未转染DC相比显著升高[(84.9±5.5)%vs(68.0±5.8)%,P=0.026],CD80的表达也显著升高([88.2±3.9)%vs(61.1±4.4)%,P=0.015]。低剂量5-Aza-CdR处理后的C666-1细胞凋亡情况与未处理的细胞相比无显著差异。经低浓度5-Aza-CdR预处理的C666-1细胞中IRF7基因表达与未处理的细胞相比显著升高(P=0.0001)。与空载的DC相比,EBNA1-DC诱导的淋巴细胞对EBV阳性表达的C666-1细胞具有更强的特异性杀伤活性(P=0.049);经低浓度5-Aza-CdR预处理的C666-1细胞对EBNA1-DC诱导的特异性免疫杀伤更敏感(P=0.019)。结论:5-Aza-CdR与EBNA1-DC疫苗联合可显著增强对C666-1细胞的特异性免疫杀伤,本研究为开拓以mRNA为基础的DC疫苗及其在临床综合治疗中的应用转化提供前期研究基础。 展开更多
关键词 EB病毒核抗原1 甲基化抑制剂 5-AZA-CDR Epstein Barr病毒 DC疫苗 鼻咽癌
下载PDF
Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection 被引量:11
9
作者 ZHANG Wen-yan LI Gan-di +4 位作者 LIU Wei-ping OUYANG Qin REN Xing-chang LI Feng-yuan XU Huan 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第18期1542-1548,共7页
Background Intestinal T-cell lymphoma (ITCL) is a heterogeneous lymphoid neoplastic group with variable clinical and pathological features. ITCL in oriental countries is different from enteropathy-type intestinal T-... Background Intestinal T-cell lymphoma (ITCL) is a heterogeneous lymphoid neoplastic group with variable clinical and pathological features. ITCL in oriental countries is different from enteropathy-type intestinal T-cell lymphoma (ETCL) in relation to celiac disease and Epstein-Barr virus (EBV). The objective of this study was to investigate the clinicopathological features, immunophenotype, expression of cytotoxic molecule (TIA-1), T-cell receptor (TCR)-γ gene rearrangement, and Epstein-Barr virus (EBV) latent infection in primary ITCL without celiac disease in Chinese. Methods The clinical data of 42 patients were analyzed, and the patients were followed up. Compared with human reactive lymphoid tissues, in situ hybridization for EBER1/2, polymerase chain reaction for TCR-~/gene rearrangement, and immunohistochemical staining for immunophenotypes, TIA-1 and EBV latent membrane proteins (LMP-1) were investigated. Survival curves of different clinicopathological features, immunophenotypes, expression of LMPI , TCR-γ/gene rearrangement and therapy were analyzed. Results Three fourths of the patients suffered from ITCL in China were men with a peak age incidence in the 4th decade. Common presenting features included fever and hemotochezia. The prognosis was poor with a median survival of 3.0 months. The lesions were mostly localized in the ileocecum and colon. About 38/42 (90. 5% ) patients demonstrated pleomorphic medium-sized on large seen. All 42 patients with ITCL revealed CD45RO cells. Histological features of celiac disease were rarely positive. Neoplastic cells partially expressed T-cell differentiated antigens (CD3ε, CD4, CD8) and NK cell associated antigen (CD56). The positive frequency of CD3e, CIM, CD8 and CD56 was 28/42 (66.7%) 7/42 (16.7%), 10/42 (23.8%) and 12/42 (28.6%) respectively. Thirty-nine cells (92. 9% ) expressed TIA-1, but none expressed CD20 and CD68. More than half of the patients (64. 3% , 64.3% and 59.5% ) revealed TCR-γ primers respectively. EBER1/2 was detected in 41 (97.6%) of LMP-1 was 38. 1% (16/42). gene rearrangement by three different TCR-γ the 42 patients. The expression frequency ofConclusions Primary ITCL without celiac disease in Chinese is a special highly EBV-associated clinicopathological entity. There are few similarities in patients with celiac disease in western countries. A small proportion of primary ITCLs in Chinese and extranodal NK/T-eell lymphoma of nasal type belong to the same speetrum. 展开更多
关键词 intestinal T-cell lymphoma·pathology·immunophenotype·gene rearrangement gamma-chain T-cell antigen receptor·epstein-barr virus
原文传递
丙型肝炎病毒非结构蛋白4B对肝癌细胞增殖的影响 被引量:1
10
作者 杨春 陈文 +3 位作者 钟晓琳 王忠琼 陈枫 夏纪毅 《山东医药》 CAS 2012年第32期31-33,I0002,共4页
目的探讨丙型肝炎病毒非结构蛋白4B(HCV-NS4B)对肝癌细胞增殖及增殖细胞核抗原(PCNA)和周期素D1(cyclinD1)蛋白表达的影响。方法采用构建好的HCV-NS4B表达载体,以脂质体转染法转染HepG2细胞。RT-PCR、琼脂糖凝胶电泳证实HCV-NS4B在HepG... 目的探讨丙型肝炎病毒非结构蛋白4B(HCV-NS4B)对肝癌细胞增殖及增殖细胞核抗原(PCNA)和周期素D1(cyclinD1)蛋白表达的影响。方法采用构建好的HCV-NS4B表达载体,以脂质体转染法转染HepG2细胞。RT-PCR、琼脂糖凝胶电泳证实HCV-NS4B在HepG2细胞稳定表达。MTT法绘制生长曲线,观察NS4B对肝细胞生长的影响;流式细胞仪检测细胞周期的情况;免疫细胞化学法检测PCNA和cyclinD1的表达。结果转染后,生长曲线显示NS4B可促进肝细胞生长;细胞周期检测显示转染NS4B的HepG2细胞进入S期和G2/M期增多(P<0.05),处于G0/G1期细胞降低(P<0.05)。PCNA和cyclinD1的表达均较空白载体组升高(P<0.05)。结论HCV-NS4B可干扰肝癌细胞周期,促进肝癌细胞增殖,其作用与上调PCNA、cyclinD1表达有关。 展开更多
关键词 丙型肝炎病毒非结构蛋白4B 肝肿瘤 增殖细胞核抗原 周期素蛋白D1
下载PDF
人H7N9禽流感病毒、高致病H5N1禽流感病毒及H1N1流感病毒感染小鼠特征分析 被引量:5
11
作者 刘晨风 吴小红 +6 位作者 赵光宇 高同同 曾扬 唐健 于虹 孙世惠 周育森 《中国实验动物学报》 CAS CSCD 2014年第1期8-12,I0004-I0005,共7页
目的对比分析人高致病H5N1禽流感病毒、H7N9禽流感病毒及H1N1流感病毒分别感染BALB/c小鼠后的机体反应特征。方法分别以H7N9病毒、H5N1病毒和H1N1病毒滴鼻感染BALB/c小鼠,观察小鼠存活率、体征变化及感染后肺组织病理损伤差异,检测小鼠... 目的对比分析人高致病H5N1禽流感病毒、H7N9禽流感病毒及H1N1流感病毒分别感染BALB/c小鼠后的机体反应特征。方法分别以H7N9病毒、H5N1病毒和H1N1病毒滴鼻感染BALB/c小鼠,观察小鼠存活率、体征变化及感染后肺组织病理损伤差异,检测小鼠感染流感病毒后肺组织增殖细胞核抗原(PCNA)表达并观察小鼠感染后修复状况。结果 H7N9病毒、H5N1病毒和H1N1病毒均感染BALB/c小鼠,小鼠存活率依次为H7N9>H1N1>H5N1,肺组织病理损伤严重程度依次为H5N1>H1N1>H7N9,PCNA表达水平依次为H7N9>H1N1>H5N1。结论 H7N9病毒感染后宿主炎症反应较小,感染后小鼠肺组织自我修复能力较强;H5N1病毒感染BALB/c小鼠后的机体反应最为强烈,感染后恢复能力差,致死率高。 展开更多
关键词 流感病毒 急性肺损伤 恢复 增殖核细胞抗原
下载PDF
自身抗体对乙型肝炎病毒相关性肾炎的诊断和预测价值 被引量:2
12
作者 耿丽娜 张璧珠 李宝亮 《国际检验医学杂志》 CAS 2019年第9期1090-1092,1097,共4页
目的通过检测乙型肝炎病毒相关性肾炎(HBV-GN)患者血清中的自身抗体,分析自身抗体在HBV-GN中的诊断和预测价值,从而为该病的防治提供新的思路。方法对23例HBV-GN和25例乙型肝炎非肾炎患者进行病例分析,并采用间接免疫荧光法和免疫印迹... 目的通过检测乙型肝炎病毒相关性肾炎(HBV-GN)患者血清中的自身抗体,分析自身抗体在HBV-GN中的诊断和预测价值,从而为该病的防治提供新的思路。方法对23例HBV-GN和25例乙型肝炎非肾炎患者进行病例分析,并采用间接免疫荧光法和免疫印迹法分别检测患者血清抗核抗体(ANA)和抗可溶性核抗原(ENA)抗体,比较每组抗核抗体的阳性率和核型以及抗ENA抗体谱的阳性率和种类,并对乙型肝炎非肾炎患者进行随访。结果 HBV-GN患者抗核抗体和抗ENA抗体谱阳性率显著增高,其中ANA核型以颗粒型为主,抗ENA抗体谱中Ro-52和AMA-M2居多,且自身抗体阳性的乙肝患者更易发生HBV-GN。结论自身抗体在乙型肝炎病毒相关性肾炎中有一定的检测价值,可以为疾病的预测和早期诊断提供新的参考指标。 展开更多
关键词 乙型肝炎病毒相关性肾炎 抗核抗体 抗ENA抗体谱 自身抗体
下载PDF
鼻咽癌血清中EB病毒核抗原-1和核抗原-2抗体的研究 被引量:2
13
作者 黄平 吴荫棠 +1 位作者 郭辉玉 汪慧民 《中山医科大学学报》 CSCD 1992年第1期16-19,共4页
用抗补体免疫荧光法检测鼻咽癌患者和对照人群中EB病毒核抗原-1(EBNA-1)和EB病毒核抗原-2(EBNA-2)抗体的水平。鼻咽癌组中两种抗体滴度都升高,以EBNA-1抗体上升明显;且EBNA-1抗体与总EBNA抗体水平的变化趋势相一致。鼻咽增生性病变组中E... 用抗补体免疫荧光法检测鼻咽癌患者和对照人群中EB病毒核抗原-1(EBNA-1)和EB病毒核抗原-2(EBNA-2)抗体的水平。鼻咽癌组中两种抗体滴度都升高,以EBNA-1抗体上升明显;且EBNA-1抗体与总EBNA抗体水平的变化趋势相一致。鼻咽增生性病变组中EBNA-2抗体略占优势,该组中EBNA-2抗体水平升高可能与潜伏状态的EB病毒激活或再感染的早期阶段有关。 展开更多
关键词 E-B病毒 核抗原 鼻咽肿瘤
下载PDF
抗核抗体和疱疹病毒IgG类抗体间的相关性 被引量:1
14
作者 刘若英 袁薇 +3 位作者 朱晓萍 余芳 曾丽 左丽 《贵阳医学院学报》 CAS 1998年第3期261-263,共3页
用ELISA间接法检测了人血清中的CMV和HSVⅠIgG类抗体,48份间接荧光免疫技术检测的ANA阳性血清和57份ANA阴性血清,CMVIgG类抗体阳性率分别为69%和39%。31份免疫印迹法检测的ENA抗体阳性血... 用ELISA间接法检测了人血清中的CMV和HSVⅠIgG类抗体,48份间接荧光免疫技术检测的ANA阳性血清和57份ANA阴性血清,CMVIgG类抗体阳性率分别为69%和39%。31份免疫印迹法检测的ENA抗体阳性血清和62份ENA阴性血清,CMVIgG类抗体阳性率分别为71%和42%,两类抗核抗体阳性组和阴性组间CMVIgG类抗体阳性率有显著性差异,但HSVⅠIgG类抗体水平在这些抗核抗体阴性、阳性组间的差异不具显著性。 展开更多
关键词 疱疹病毒 抗体 抗核抗体 IGG抗体 ENA抗体
下载PDF
HSV-2感染及其PCNA表达与宫颈癌关系的研究 被引量:6
15
作者 庄坚 林莹 +2 位作者 李曼红 谢斌 曾庆纯 《汕头大学医学院学报》 2001年第3期163-165,共3页
目的 :探讨HSV 2感染及其PCNA表达与宫颈癌的关系。方法 :采用PCR技术、免疫组化SP法检测同一宫颈癌变组织的HSV 2感染及其PCNA表达情况 ,并与非癌变组织进行比较。结果 :①84例宫颈癌组织中HSV 2DNA阳性率、HSV 2和PCNA表达率分别为 48... 目的 :探讨HSV 2感染及其PCNA表达与宫颈癌的关系。方法 :采用PCR技术、免疫组化SP法检测同一宫颈癌变组织的HSV 2感染及其PCNA表达情况 ,并与非癌变组织进行比较。结果 :①84例宫颈癌组织中HSV 2DNA阳性率、HSV 2和PCNA表达率分别为 48 8%、 34 5 %和 71 4% ;②5 9例非癌变组织中 ,尖锐湿疣和正常宫颈组织的HSV 2DNA阳性率、PCNA表达率依次为 2 1 7%和 15 4%、 37 0 %和 7 7% ;尖锐湿疣的HSV 2表达率为 15 2 %。结论 :汕头地区宫颈癌的发生与较高的HSV 展开更多
关键词 单纯疱疹病毒 宫颈肿瘤 增殖细胞核抗原 PCNA HSV-2
下载PDF
V-val突变型EB病毒核抗原1的功能研究
16
作者 买世娟 李大疆 +5 位作者 周昕熙 陈丽珍 冯启胜 张如华 余杏娟 曾益新 《癌症》 SCIE CAS CSCD 北大核心 2008年第3期231-236,共6页
背景与目的:EB病毒核抗原1(Epstein-Barr viral nuclear antigen 1,EBNA 1)对于维持EB病毒的潜伏感染有重要作用。V-val变异型的EBNA1与鼻咽癌有密切的相关性。本研究旨在比较原型和V-val变异型的EBNA1基因在上皮细胞中的功能的差异。方... 背景与目的:EB病毒核抗原1(Epstein-Barr viral nuclear antigen 1,EBNA 1)对于维持EB病毒的潜伏感染有重要作用。V-val变异型的EBNA1与鼻咽癌有密切的相关性。本研究旨在比较原型和V-val变异型的EBNA1基因在上皮细胞中的功能的差异。方法:用PCR方法扩增出原型和V-val变异型EBNA1基因的全长并克隆到pGFP载体上,转染HEK293细胞,检测两种亚型的EBNA1蛋白的表达对细胞生物学性状的影响。以含有EB病毒增强子FR序列的荧光素酶载体作为报告基因,比较两种亚型的EBNA1基因对质粒的转录激活能力。结果:原型和V-val变异型EBNA1基因的表达对HEK293细胞的生长速度没有明显影响,但表达原型EBNA1的细胞的克隆形成能力明显低于V-val亚型。在裸鼠致瘤实验中,接种表达原型和V-val变异型EBNA1细胞的实验组均未见肿瘤形成。但是在瞬时转染实验中,表达V-val变异型EBNA1基因的HEK293细胞的荧光素酶活性明显高于原型EBNA1基因。结论:原型和变异型EBNA1均未发现有明显的转化细胞的能力,但是V-val变异型EBNA1蛋白与原型相比,其转录激活的功能明显增强。 展开更多
关键词 鼻咽肿瘤 EB病毒 EB病毒核抗原1 变异型
下载PDF
EB病毒特异性增强子CAT报告质粒构建策略
17
作者 廖志勇 车小燕 +3 位作者 徐华 张丽娅 潘玉先 郝卫 《生物技术通讯》 CAS 2004年第3期213-215,共3页
构建携带EB病毒特异性增强子oriP不同结构域的CAT报告质粒,以探讨EB病毒特异性增强子与EB病毒核抗原-1结合后的转录增强作用。聚合酶链反应扩增得到增强子oriP全序列,借助于pUC19质粒将其不同结构域克隆到pCAT3Promoter(pCAT3/P)载体。... 构建携带EB病毒特异性增强子oriP不同结构域的CAT报告质粒,以探讨EB病毒特异性增强子与EB病毒核抗原-1结合后的转录增强作用。聚合酶链反应扩增得到增强子oriP全序列,借助于pUC19质粒将其不同结构域克隆到pCAT3Promoter(pCAT3/P)载体。扩增获得oriP全序列;构建得到携带EB病毒特异性增强子Orip不同结构域的CAT报告质粒pCAT3/P-oriP、pCAT3/P-FR、pCAT3/P-DS、pCAT3/P-(FR+DS)等,质粒中目的基因的插入方向经鉴定正确。 展开更多
关键词 epstein-barr病毒 特异性增强子 核心抗原-l 目的基因 CAT报告质粒
下载PDF
肝硬化患者检测p21、IGF-Ⅱ及PCNA的意义
18
作者 冯震博 吕自力 何如昆 《临床肝胆病杂志》 CAS 北大核心 2002年第6期346-347,共2页
探讨p2 1、IGF -Ⅱ、PCNA的相互关系及它们在肝硬化、肝细胞不典型增生 (LCD)、肝细胞癌 (HCC)形成中的作用。用S -P法对 5 0例单纯肝硬化、2 8例癌旁肝硬化及 2 2例HCC的p2 1、IGF -Ⅱ、PCNA表达情况进行检测。癌旁肝硬化、单纯肝硬化... 探讨p2 1、IGF -Ⅱ、PCNA的相互关系及它们在肝硬化、肝细胞不典型增生 (LCD)、肝细胞癌 (HCC)形成中的作用。用S -P法对 5 0例单纯肝硬化、2 8例癌旁肝硬化及 2 2例HCC的p2 1、IGF -Ⅱ、PCNA表达情况进行检测。癌旁肝硬化、单纯肝硬化、HCC中p2 1阳性率分别为 92 86 %、6 8%、5 4 5 5 % ;IGF -Ⅱ阳性率分别为 75 %、74 %、36 36 %。肝硬化与HCC之间差别有显著性意义 (P <0 0 5 )。伴LCD改变或HBsAg阳性的肝硬化 ,P2 1、IGF -Ⅱ、PC NA阳性表达率均高于不伴LCD改变或HBsAg阴性的肝硬化组织 (P <0 0 5 )。PCNA阳性及IGF -Ⅱ阳性的肝硬化组织 ,其p2 1阳性表达率均高于PCNA阴性及IGF -Ⅱ阴性的肝硬化组织 (P <0 0 1)。 (1)HBV感染与p2 1、IGF -Ⅱ、PCNA表达密切相关 ,它们在致肝细胞癌变过程中可能具有协同作用。 (2 )LCD是一群具有肿瘤增殖潜能的癌前细胞群 ,尤其是伴HBV感染且P2 1、IGF -Ⅱ、PCNA共同过量表达者 。 展开更多
关键词 ras癌基因产物蛋白p21 胰岛素样生长因子-Ⅱ 乙型肝炎病毒 肝硬化 肝细胞癌 免疫组化
下载PDF
EBNA-1的功能特点与基因治疗
19
作者 何玉文 陈宏远 杜军 《中山大学研究生学刊(自然科学与医学版)》 2007年第4期1-8,共8页
EB病毒(EBV)与多种恶性肿瘤的发生、发展密切相关。EBNA-1是EBV潜伏感染时编码的一种核蛋白,它能调节EBV基因的复制,增强病毒基因的转录,并能保证EBV以附加体的形式稳定存在于被感染的细胞内。利用此蛋白上述两种功能特点,研究者构建了... EB病毒(EBV)与多种恶性肿瘤的发生、发展密切相关。EBNA-1是EBV潜伏感染时编码的一种核蛋白,它能调节EBV基因的复制,增强病毒基因的转录,并能保证EBV以附加体的形式稳定存在于被感染的细胞内。利用此蛋白上述两种功能特点,研究者构建了EBV复制子载体,这种载体已被广泛地应用于基因治疗。 展开更多
关键词 EB病毒 EBV核蛋白1 EBV复制子载体 基因治疗
下载PDF
P^(21)和PCNA在肝硬变组织中表达的研究
20
作者 冯震博 何如昆 《广西医科大学学报》 CAS 2000年第3期362-364,共3页
目的 :探讨 P2 1 、 PCNA的相互关系及它们在肝硬变、肝细胞不典型增生 ( L CD)、肝细胞癌 ( HCC)形成中的作用。方法 :运用 S- P法对 6 0例单纯肝硬变 (不伴癌 )、 30例癌旁肝硬变及 2 7例 HCC的 P2 1、HBs Ag及 PCNA表达情况进行实验... 目的 :探讨 P2 1 、 PCNA的相互关系及它们在肝硬变、肝细胞不典型增生 ( L CD)、肝细胞癌 ( HCC)形成中的作用。方法 :运用 S- P法对 6 0例单纯肝硬变 (不伴癌 )、 30例癌旁肝硬变及 2 7例 HCC的 P2 1、HBs Ag及 PCNA表达情况进行实验研究。结果 :癌旁肝硬变组织、单纯肝硬变组织、癌组织 P2 1 阳性率分别为 90 % ,6 8.33% ,6 2 .96 % ,癌旁肝硬变与单纯肝硬变、癌旁肝硬变与癌组织之间差别有显著性意义 ( P <0 .0 5 )。伴 L CD改变或 HBs Ag阳性的肝硬变组织 ,P2 1阳性率分别为92 .45 % ,87.32 % ,明显高于不伴 L CD改变或 HBs Ag阴性的肝硬变组织 ( P <0 .0 1) ,P2 1 的表达与 HBs Ag感染有关。PCNA阳性的 5 8例肝硬变中有 5 0例呈 P2 1 阳性 ,而 PCNA阴性的 32例肝硬变组织中仅有 18例呈 P2 1 阳性 ,PCNA与 P2 1 表达呈正相关。结论 :1P2 1的过度表达可能与肝细胞癌的起始过程有关 ,在 HCC形成发展的早期阶段发挥重要作用 ;2 HBV感染及PCNA与 P2 1 表达密切相关 ,有 HBV感染的肝细胞 ,尤其是同时表达 PCNA的肝细胞 ,具有活跃的增殖能力 ,P2 1 表达增高 ;3L CD是一群具有肿瘤性增殖潜能的癌前细胞群 ,尤其是伴有 HBV感染 ,且有 P2 1及 PCNA共同过量表达者 。 展开更多
关键词 PCNA 肝硬变 P21 S-P法 RAS基因
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部